Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of a Human Monoclonal Antibody for Inhalational Anthrax
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biochemical, Biophysical, and Structural Mechanisms of HIV-1 Budding and Release
Enhancing basic and translational TB research in northern Vietnam
Macgn
Superoxide Dismutase Gene Regulation in Rat Lung Injury
Cross National Supplement to Quality of Life Survey in Slovenia
Recently added grants:
Molecular study mouse virus resistance mechanisms
Biochemical, Biophysical, and Structural Mechanisms of HIV-1 Budding and Release
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
Development of Ad26/Env Vaccines for HIV
ORMDL3-ceramide axis in allergic asthma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200700033C-2-0-1
Application #
7567309
Study Section
Project Start
2007-09-28
Project End
2011-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/ Pharmathene, Inc.
$1,998,109
NIH 2007
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/
Comments
Be the first to comment on this grant